This site is intended for US audiences only. If you are a resident of the European Union, please click here for the EU version of our site.
Flow Cytometry for Hematopathologists
The International Clinical Cytometry Society (ICCS) PNH Webcast Is Now Available!
You can now watch an ICCS-sponsored, 60-minute Webcast outlining new ICCS guidelines for the diagnosis and monitoring of PNH.
Featured speakers:
Michael J. Borowitz, MD, PhD
Professor of Pathology and Oncology, Director of Hematologic Pathology, Johns Hopkins Medical Institutions
Wendell F. Rosse, MD
Florence McAlister Professor of Medicine, Emeritus, Duke University Medical Center
The Presentation Addresses:
- The pathophysiology, clinical manifestation, and consequences associated with PNH
- Recommendations on the evaluation of high-risk patient populations who should be tested for PNH
- Flow cytometry procedures and strategies for detecting PNH cells/clones under routine, as well as high-sensitivity, methodologies
Flow Cytometry: The Most Sensitive, Informative Assay for PNH Diagnosis
Detection of PNH clones by flow cytometry via peripheral blood, the gold standard diagnostic test for PNH, provides the most consistent and sensitive method of testing for PNH. The International Clinical Cytometry Society (ICCS) has published guidelines to support the accurate identification and monitoring of PNH cell populations.1
Now you can more accurately identify and monitor PNH in your practice. Click here to view the full ICCS guidelines.
1. Borowitz MJ, Craig FE, DiGiuseppe JA, et al; for Clinical Cytometry Society. Cytometry Part B Clin Cytom. doi:10.1002/cyto.b.20525.
Some of the consequences of hemolysis include stroke or TIA, pulmonary embolism or DVT, and end-organ damage to the brain, liver, gastrointestinal tract, or lungs.